KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Return on Invested Capital (2020 - 2025)

Historic Return on Invested Capital for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Q3 2025 value amounting to 0.16%.

  • Aurinia Pharmaceuticals' Return on Invested Capital rose 2400.0% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 0.01% for FY2024, which is 2000.0% up from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' Return on Invested Capital stood at 0.16%, which was up 2400.0% from 0.12% recorded in Q2 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Return on Invested Capital peaked at 0.16% during Q3 2025, and registered a low of 0.6% during Q3 2021.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.2% (2023), whereas its average is 0.21%.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Return on Invested Capital soared by 3300bps in 2022, and later skyrocketed by 500bps in 2024.
  • Over the past 5 years, Aurinia Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.47% in 2021, then soared by 41bps to 0.27% in 2022, then increased by 29bps to 0.2% in 2023, then skyrocketed by 96bps to 0.01% in 2024, then soared by 2164bps to 0.16% in 2025.
  • Its Return on Invested Capital stands at 0.16% for Q3 2025, versus 0.12% for Q2 2025 and 0.07% for Q1 2025.